Sonoma Pharmaceuticals, Inc. (SNOA)

Last Closing Price: 0.81 (2026-11-19)

Gross Profit (Quarterly)

Gross Profit: Revenues from operations less the associated costs.

Sonoma Pharmaceuticals, Inc. (SNOA) had Gross Profit of $2.81M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$7.17M
$-0.07M
$4.37M
Gross Profit
$2.81M
$6.88M
$0.29M
$0.09M
$0.38M
$0.38M
$-0.07M
$-0.07M
$-0.07M
$-0.07M
$0.29M
$0.32M
4.91M
4.91M
$-0.01
$-0.01
Balance Sheet Financials
$15.34M
$0.29M
$1.76M
$17.10M
$4.42M
--
$6.07M
$10.49M
$6.61M
$6.61M
$6.61M
5.06M
Cash Flow Statement Financials
$-1.39M
$-0.04M
$3.69M
$2.40M
$4.61M
$2.21M
$0.15M
--
--
Fundamental Metrics & Ratios
3.48
--
--
--
0.01
39.13%
4.04%
4.04%
--
5.32%
-0.92%
$-1.43M
--
--
--
0.42
1.24
2.00
44.94
-1.00%
-1.00%
-0.39%
-1.00%
$1.31
$-0.29
$-0.28